EP3257500

BRISTOL MYERS SQUIBB IRELAND
Application Number
EP17178613A
Filing Date
Feb 24, 2011
Status
Revoked
Mar 22, 2024
Grant Date
Oct 16, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP3257500B1 was granted to Bristol Myers Squibb Ireland on Oct 16, 2019 following the initial filing on Feb 24, 2011 under the application number EP17178613A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKJul 16, 2020ADMISSIBLE
STADA ARZNEIMITTELJul 16, 2020ADMISSIBLE
SANDOZJul 15, 2020ADMISSIBLE
INTAS PHARMACEUTICALSJul 15, 2020WITHDRAWN
KRKAJul 15, 2020WITHDRAWN
MEDICHEMJul 14, 2020ADMISSIBLE
TEVA PHARMACEUTICALSJul 14, 2020ADMISSIBLE
KUTZENBERGER WOLFF & PARTNERJul 13, 2020ADMISSIBLE
ZENTIVA KSJul 13, 2020ADMISSIBLE
POLPHARMAJul 2, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents